Topic Highlight
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. May 28, 2014; 20(20): 6244-6251
Published online May 28, 2014. doi: 10.3748/wjg.v20.i20.6244
Figure 1
Figure 1 Known risk factors for hepatocellular carcinoma disease progression for chronic hepatitis B. M: Male; F: Female; HBV: Hepatitis B virus; HBeAg: Hepatitis B e antigen.
Figure 2
Figure 2 The updated REVEAL nomogram for the prediction of hepatocellular carcinoma risk. HCC: Hepatocellular carcinoma.
Figure 3
Figure 3 The distributions of score in the derivation cohort (from community) and the validation cohort (from clinical settings) used in the REACH-B study[13].